Processes of plasma protein N-homocysteinylation in multiple sclerosis

References

• Guthikonda S, Haynes WG. Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep 2006;8(2):100–6.
   PubMedGoogle Scholar
• Jakubowski H, Boers GH, Strauss KA. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase n-homocysteinylated protein levels in humans. Faseb J 2008;22(12):4071–6.
   PubMed Web of Science ®Google Scholar
• Hooshmand B, Solomon A, Kåreholt I. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology 2010;75(16):1408–14.
   PubMed Web of Science ®Google Scholar
• Seshadri S. Homocysteine and the risk of dementia. Clin Chem 2012;58(6):1059–60.
   PubMed Web of Science ®Google Scholar
• Sławek J, Roszmann A, Robowski P. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors. Neurodegener Dis 2013;12(1):1–12.
   PubMed Web of Science ®Google Scholar
• Jakubowski H, Głowacki R. Chemical biology of homocysteine thiolactone and related metabolites. Adv Clin Chem 2011;55:81–103.
   PubMed Web of Science ®Google Scholar
• Undas A, Perla J, Lacinski M. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 2004;35(6):1299–304.
   PubMed Web of Science ®Google Scholar
• Undas A, Kolarz M, Kopec G. Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis. Nephrol Dial Transpl 2007;22(6):1685–9.
   PubMed Web of Science ®Google Scholar
• Padjas A, Undas A, Swadzba J. Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus. Pol Arch Med Wewn 2007;117(3):20–5.
   PubMedGoogle Scholar
• Zoccolella S, Tortorella C, Iaffaldano P. Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender. J Neurol 2012;259(10):2105–10.
   PubMed Web of Science ®Google Scholar
• Vrethem M, Mattsson E, Hebelka H. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler 2003;9(3):239–45.
   PubMed Web of Science ®Google Scholar
• Teunissen CE, Killestein J, Kragt JJ. Serum homocysteine levels in relation to clinical progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008;79(12):1349–53.
   PubMed Web of Science ®Google Scholar
• Ayub A, Mackness MI, Arrol S. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999;19(2):330–5.
   PubMed Web of Science ®Google Scholar
• Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 2000;275(6):3957–62.
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239(1):70–6.
   PubMed Web of Science ®Google Scholar
• Beltowski J, Wójcicka G, Jakubowski H. Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat. J Endocrinol 2010;204(2):191–8.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499–502.
   PubMed Web of Science ®Google Scholar
• Kuszczyk M, Gordon-Krajcer W, Lazarewicz JW. Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau. Neurochem Int 2009;55(1–3):174–80.
   PubMed Web of Science ®Google Scholar
• Chan AY, Alsaraby A, Shea TB. Folate deprivation increases tau phosphorylation by homocysteine-induced calcium influx and by inhibition of phosphatase activity: alleviation by S-adenosyl methionine. Brain Res 2008;1199:133–7.
   PubMed Web of Science ®Google Scholar
• Yeganeh F, Nikbakht F, Bahmanpour S. Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study. J Mol Neurosci 2013;50(3):551–7.
   PubMed Web of Science ®Google Scholar
• Mendoza-Oliva A, Ferrera P, Arias C. Interplay between cholesterol and homocysteine in the exacerbation of amyloid-β toxicity in human neuroblastoma cells. CNS Neurol Disord Drug Targets 2013;12(6):842–8.
   PubMed Web of Science ®Google Scholar
• Schaub C, Uebachs M, Beck H. Chronic homocysteine exposure causes changes in the intrinsic electrophysiological properties of cultured hippocampal neurons. Exp Brain Res 2013;225(4):527–34.
   PubMed Web of Science ®Google Scholar
• Moghaddasi M, Mamarabadi M, Mohebi N. Homocysteine, vitamin B12 and folate levels in Iranian patients with multiple sclerosis: a case control study. Clin Neurol Neurosurg 2013;115(9):1802–5.
   PubMed Web of Science ®Google Scholar
• Zhu Y, He ZY, Liu HN. Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis. J Clin Neurosci 2011;18(7):933–8.
   PubMed Web of Science ®Google Scholar
• Triantafyllou N, Evangelopoulos ME, Kimiskidis VK. Increased plasma homocysteine levels in patients with multiple sclerosis and depression. Ann Gen Psychiatry 2008;7:17.
   PubMedGoogle Scholar
• Besler HT, Comoğlu S. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci 2003;6(3):189–96.
   PubMed Web of Science ®Google Scholar
• Russo C, Morabito F, Luise F. Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol 2008;255(1):64–9.
   PubMed Web of Science ®Google Scholar
• Kararizou E, Paraskevas G, Triantafyllou N. Plasma homocysteine levels in patients with multiple sclerosis in the Greek population. J Chin Med Assoc 2013;76(11):611–4.
   PubMed Web of Science ®Google Scholar
• Aksungar FB, Topkaya AE, Yildiz Z. Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci 2008;15(4):393–7.
   PubMed Web of Science ®Google Scholar
• Jakubowski H, Perla-Kaján J, Finnell RH. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J 2009;23(6):1721–7.
   PubMed Web of Science ®Google Scholar
• Zimny J, Sikora M, Guranowski A. Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase. J Biol Chem 2006;281(32):22485–92.
   PubMed Web of Science ®Google Scholar
• Montoya SE, Thiels E, Card JP. Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase. Neuroscience 2007;146(3):890–900.
   PubMed Web of Science ®Google Scholar
• Smach MA, Charfeddine B, Lammouchi T. Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer's disease. Neurol Sci 2010;31(6):687–91.
   PubMed Web of Science ®Google Scholar
• Suszynska J, Tisonczyk J, Lee HG. Reduced homocysteine-thiolactonase activity in Alzheimer's disease. J Alzheimers Dis 2010;19(4):1177–83.
   PubMed Web of Science ®Google Scholar
• Borowczyk K, Tisończyk J, Jakubowski H. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase. Amino Acids 2012;43(3):1339–48.
   PubMed Web of Science ®Google Scholar